Literature DB >> 11967174

Epilepsy and epileptic disorders, an epidemiological marker? Contribution of descriptive epidemiology.

Pierre Jallon1.   

Abstract

Numerous epidemiological studies concerning the incidence and prevalence of epilepsy and epileptic seizures have been performed in different geographical areas throughout the world. The results of these studies show some disparities in the evaluation of incidence and prevalence rates. Higher incidence rates have been reported in a few studies performed in developing countries. Many prevalence studies seem to corroborate this figure although more recent surveys report similar rates to those observed in the developed world. These controversial results are discussed because there is no scientific reason that the clinical aspects and natural evolution of the disease should be different between developed and developing countries. However, some epidemic or endemic diseases might explain, in part, these figures. On the other hand, the age and sex distribution of the disease seems to be specific to epilepsy and could be related to particular risk factors and some demographic considerations. Apart from obvious methodological biases, the results of these studies lead us to recognize that epilepsy is universal it can occur in any people and is ubiquitous i.e. it is observed in every country but is not an equally distributed disease. Epileptic seizures and epilepsy might be considered as an epidemiological marker of some endemo-epidemic diseases or the results of certain preventive measures.

Entities:  

Mesh:

Year:  2002        PMID: 11967174

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  5 in total

1.  Complementary and alternative medicine use among US adults with common neurological conditions.

Authors:  Rebecca Erwin Wells; Russell S Phillips; Steven C Schachter; Ellen P McCarthy
Journal:  J Neurol       Date:  2010-06-11       Impact factor: 4.849

2.  Management of epilepsy in brain tumors.

Authors:  Marta Maschio; Umberto Aguglia; Giuliano Avanzini; Paola Banfi; Carla Buttinelli; Giuseppe Capovilla; Marina Maria Luisa Casazza; Gabriella Colicchio; Antonietta Coppola; Cinzia Costa; Filippo Dainese; Ornella Daniele; Roberto De Simone; Marica Eoli; Sara Gasparini; Anna Teresa Giallonardo; Angela La Neve; Andrea Maialetti; Oriano Mecarelli; Marta Melis; Roberto Michelucci; Francesco Paladin; Giada Pauletto; Marta Piccioli; Stefano Quadri; Federica Ranzato; Rosario Rossi; Andrea Salmaggi; Riccardo Terenzi; Paolo Tisei; Flavio Villani; Paolo Vitali; Lucina Carla Vivalda; Gaetano Zaccara; Alessia Zarabla; Ettore Beghi
Journal:  Neurol Sci       Date:  2019-08-07       Impact factor: 3.307

Review 3.  Challenges in the management of epilepsy in resource-poor countries.

Authors:  Kurupath Radhakrishnan
Journal:  Nat Rev Neurol       Date:  2009-05-19       Impact factor: 42.937

4.  Respiratory distress syndrome in preterm infants and risk of epilepsy in a Danish cohort.

Authors:  Sandra Kruchov Thygesen; Morten Olsen; Lars Pedersen; Victor W Henderson; John Rosendahl Østergaard; Henrik Toft Sørensen
Journal:  Eur J Epidemiol       Date:  2017-09-08       Impact factor: 8.082

5.  Spectrum of epilepsy - prevalence, impact, and treatment gap: an epidemiological study from Al-Quseir, Egypt.

Authors:  Hamdy N El-Tallawy; Wafaa M Farghaly; Tarek A Rageh; Ghaydaa A Shehata; Nabil A Metwally; Reda Badry; Mohammed A Sayed; Ahmed M Abdelwarith; Mahmoud R Kandil; Mohamed A Hamed; Khaled O Mohamed; Amal M Tohamy
Journal:  Neuropsychiatr Dis Treat       Date:  2016-05-12       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.